Topics
Glioblastoma | Treatment | Targeted therapy | Overview
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Overview
Shikalov A, Koman I, Kogan NM.
Targeted
Glioma Therapy-Clinical Trials and Future
Directions.
Pharmaceutics.
2024 Jan 11;16(1):100. doi:
10.3390/pharmaceutics16010100. PMID:
38258110. Review. ˍ
Jacome MA, Wu Q, Piña Y, Etame AB.
Evolution
of Molecular Biomarkers and Precision Molecular Therapeutic
Strategies in Glioblastoma.
Cancers
(Basel). 2024 Oct 29;16(21):3635. doi:
10.3390/cancers16213635. PMID:
39518074. Review. ˍ
Satish S, Athavale M, Kharkar PS.
Targeted
therapies for Glioblastoma multiforme (GBM): State-of-the-art and
future prospects.
Drug
Dev Res. 2024 Nov 1;85(7):e22261. doi:
10.1002/ddr.22261. PMID:
39485272. Review˰ ˍ
Rusak A, Wiatrak B, Krawczyńska K, Górnicki T,
Zagórski K, Zadka Ł, Fortuna W.
Starting
points for the development of new targeted therapies for
glioblastoma multiforme.
Transl
Oncol. 2024 Nov 11;51:102187. doi:
10.1016/j.tranon.2024.102187. PMID:
39531784. Review. ˍ
Ippen FM, Scherm A, Kessler T, Hau P, Agkatsev S, Baurecht H, Wick
W, Knüttel H, Leitzmann MF, Seliger-Behme C.
Targeted
agents in patients with progressive
glioblastoma-A systematic
meta-analysis of randomized clinical trials.
Cancer
Med. 2024 Jun
21;13(12):e7362. doi:
10.1002/cam4.7362. PMID:
39618405. Meta-analysis. ˍ